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USF’s	Preparedness	&	Emergency	
Response	Learning	Center
 An activity of the USF Preparedness and Emergency 
Response Learning Center (USF PERLC) . 
 Located at the University of South Florida (USF), College 
of Public Health, in Tampa, Florida.
 Develops and strengthens the public health workforce 
in Florida and nationally by delivering Public Health 
Core Competency training and educational programs.
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Funding
This course is being offered by The USF 
Preparedness and Emergency Response 
Learning Center (USF PERLC) funded by 
the Centers for Disease Control and 
Prevention.
Grant #: U90TP000414-03 
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Target	Audience
 Public health workforce
 Outreach workers
 Nurses
 Physicians
 Administrators
 Health educators
 Students and personnel in a variety of settings, including: 
• TB programs
• Managed care organizations
• Correctional facilities
• Homeless shelters
• Migrant clinics
• Substance abuse facilities
• Nursing or medical schools
• Other facilities serving persons with or at high risk of TB
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About	This	Course
 Understand the fundamentals of tuberculosis 
infection and disease.
 Participate in an exercise to develop organization 
response plans for tuberculosis control and 
prevention. 
 Participate in case studies of tuberculosis infection 
and disease. 
 Understand roles, responsibilities, and protocols 
for a case of tuberculosis, contact investigation, or 
outbreak investigation.  
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Core	Competencies	for	Public	Health		
Professionals
Analytical/Assessment Skills Domain:
 Competencies 1A1,1A2,1A8,1A10
Policy Development/Program Planning Skills:
 Competencies 2A6, 2A7,2A8, 2A10
Communication Skills Domain:
 Competencies 3A4, 3A6, 
Cultural Competency Skills Domain:
 Competencies 4A2, 4A3, 
Community Dimensions of Practice Skills:
 Competencies 5A3, 5A4, 5A7, 5A8, 5A9
Public Health Science Skills Domain:
 Competencies 6A2, 6A4, 6A5
Financial Planning and Management Skills:
 Competencies 7A2, 7A7, 7A8
Leadership and Systems Thinking Skills:
 Competencies 8A2, 8A3,8A5, 8A7,8A8
(Source:		Council	on	Linkages,	2014)
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Public	Health	Preparedness	and	
Response	Competencies
1. Model Leadership Domain:
§ Competency 1.1.  Solve problems under emergency    
conditions.
§ Competency 1.6. Act within the scope of one’s legal 
authority.
2. Communicate and Manage Information Domain:
§ Competency 2.4.  Collect data according to protocol.
§ Competency 2.5.  Manage the recoding and/or 
transcription of data according to protocol.
(Source:		CDC/ASPH,	2010)
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3.  Plan For and Improve Practice Domain:
§ Competency 3.2. Contribute expertise to the 
development of emergency plans.
§ Competency 3.3. Participate in improving the 
organization’s capacities (including, but not limited 
to programs, plans, policies, laws, and workforce 
training) 
§ Competency 3.4.  Refer matters outside one’s 
scope of legal  authority through the chain of 
command.
(Source:		CDC/ASPH,	2010)
Public	Health	Preparedness	and	
Response	Competencies
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Training	Objectives	
At the conclusion of this program, participants will be able to: 
 Describe the history of Tuberculosis (TB). 
 Explain how TB is spread (transmission). 
 Define drug-resistant TB. 
 Explain the difference between latent TB infection (LTBI) and TB 
disease. 
 Explain how LTBI and TB disease develop (pathogenesis). 
 Describe the factors that determine the infectiousness of a TB patient. 
 Utilize exercises and scenarios to determine the infectiousness of a TB 
patient. 
 Understand roles, responsibilities, and reporting protocols in the event of 
a suspected TB case, contact investigation, and/or outbreak. 
 Develop organizational response plans for TB control. 
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Key	Terms
 Procedures are detailed, step-by-step 
instructions instructing how to complete a 
specific task. 
 Policies describe the rules of an organization. 
A procedure describes in detail how a policy is 
translated into action.
 Both Policies and Procedures contribute to the 
overall efficiency and effectiveness of an 
organization by providing clearly written 
operational standards. 
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Key	Terms
 Companies should review and update 
Procedures on a regular basis to ensure 
that they accurately reflect organizational policies 
and changes in how work is done. 
 A Procedure may be written by an individual or 
an organizational committee.
 This course is created with a component to 
revise or create your organization’s protocols as 
they relate to tuberculosis control and 
prevention. 
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Creation	of	Protocols	for	
Screening/Surveillance
• Your	team/organization	will	be	given	the	following	template	to	outline	the	steps	required	
to	assemble	a	complete	protocol	for	TB	control	and	prevention	for	your	organization.
• As	you	go	through	each	section	of	the	course,	consider	the	steps	that	your	organization	
will	require	to	have	a	comprehensive	protocol.		
• At	the	conclusion	of	each	section,	your	team/organization	will	participate	in	an	activity	to	
• complete	the	template	for	screening	to	identify	individual	cases,	contact	investigations,	
and	outbreak	investigations.
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Brief History of Tuberculosis 
and Current Epidemiology
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Brief	Tuberculosis	Facts
• Tuberculosis, commonly known 
as TB, is contagious and spreads
through the air.
• If not treated, each person with active TB infects on average 
10-15 people each year.
• 2 billion people (1/3 of the world’s population) are infected 
with TB bacilli, the microbe that causes TB.
• 1 in 10 people infected with TB bacilli will become sick with 
active TB in their lifetime. 
• Persons infected with HIV are at a much greater risk.
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Brief	Tuberculosis	Facts
 If not treated, TB can be fatal.
 It was once the leading cause of death in the United 
States.
 In the early 1900s, TB killed 1 of every 7 people living in 
the U.S. and Europe.
 In the 1980s and early 1990s, the U.S. saw a resurgence 
of TB.
 TB has been on the decline since 1993 in the U.S. 
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Brief	History	of	Tuberculosis
 In the 18th & 19th centuries, TB reached 
epidemic proportions in Europe and North 
America.
 In the early 19th century, Théophile Laennec’s 
work lead to the understanding of the  pathogenesis of 
tuberculosis.
 Transmissibility of Mycobacterium tuberculosis infection 
was demonstrated by Jean-Antoine Villemin in 1865. 
 The tubercle bacillus was identified as the etiologic agent 
by Robert Koch in 1882. 
 Clemens von Pirquet developed the tuberculin skin test in 
1907 and 3 years later used it to demonstrate latent 
tuberculosis infection in asymptomatic children. 
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Brief	History	of	Tuberculosis
 In the late 19th and early 20th centuries, 
clinics were developed for the treatment of 
patients with tuberculosis.
§ The rest provided at these clinics was supplemented with 
pulmonary collapse procedures designed to rest infected parts of 
lungs and to close cavities. 
§ Public health measures to combat the spread of tuberculosis 
emerged following the discovery of its bacterial cause. 
 BCG vaccination was widely employed following World 
War I. 
 Streptomycin was discovered in 1944 and isoniazid in 
1952 for treatment and control.
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Brief	History	of	Tuberculosis
 1985–1992: Resurgence of TB in the United States, fueled by 
several factors. 
 In response to resurgence, U.S. renewed commitment and 
support for TB control.
 In 1993, upward trend was reversed; that decline has 
continued.
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1985-1992:		
Factors	Contributing	to	Increase	in	TB	
• Emerging HIV/AIDS epidemic.
• Immigration from countries where TB was common.
• Transmission of TB in congregate settings.
• Development of multidrug-resistant (MDR) TB.
Decades of funding cuts had impaired effectiveness of 
TB control programs.
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1993	– to	present	
Factors	Contributing	to	Decrease	in	TB	
Success attributed to increased efforts to:
• Promptly identify persons with TB.
• Initiate appropriate treatment.
• Ensure completion of therapy.
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Barriers	to	TB	Elimination	
 U.S. - TB cases occur largely in high-risk 
populations.
§ TB is difficult to detect, diagnose, and treat in these 
populations.
 Global TB epidemic persists.
 Current TB control measures are 
limited; new tests, vaccines, drugs 
needed.
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U.S.	TB	Trends
 1993–2013: Cases 
decreased.
 1993–2002: Cases decreased 
5%-7% annually.
 2003–2008: Decreased at a 
more moderate rate 3%-5%.
 2009: Declined 10.6% from 2008
 2010–2013: Cases resumed 
moderate decreases.  (average 
4.5% from 2009)
 9,421 TB cases (a rate of 
2.96 cases per 100,000 
persons) were reported in 
the United States in 2014.
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TB	Cases	in	Foreign-Born	Persons
 Cases among U.S. born and foreign-born persons are declining, but much less so in 
foreign-born.
 2002: First year foreign-born persons accounted for majority of U.S. TB cases (51%).
 2014 – Foreign-born cases accounted for 66% of all cases.
 The case rate among foreign-born persons (15.4 cases per 100,000 persons) in 2014 
was approximately 13 times higher than among U.S.-born persons (1.2 cases per 
100,000 persons).
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Countries	of	Birth	of	Foreign-Born	Persons	
Reported	with	TB,	United	States,	2014
TB	Case	Rates	by	Race/Ethnicity*	
United	States,	2003–2011**
M. tuberculosis (M. tb) causes most 
TB cases in U.S.
 Also called tubercule bacilli.
Mycobacteria that cause TB:
 M. tuberculosis 
 M. bovis
 M. africanum
 M. microti
 M. canetti
 M. caprae
 M. pinnipedii
 M. mungi
Mycobacteria that do not cause TB:
 M. avium complex
M.	tuberculosis
TB	Transmission	
Types	of	Mycobacteria
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 TB is spread person to person through 
airborne particles called droplet nuclei.
 M. tuberculosis may be expelled when an 
infectious person (lungs or throat):
 Coughs
 Sneezes
 Speaks  
 Sings
 Transmission occurs when another person inhales droplet nuclei. 
 People with active TB are most likely to spread it to people they 
spend time with everyday (family members, friends, coworkers, or 
schoolmates).
TB	Transmission
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TB	Transmission
Dots	in	air	represent	droplet	nuclei	containing
M.	tuberculosis
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 Probability that TB will be transmitted 
depends on:
§ Infectiousness of person with TB disease.
§ Environment in which exposure occurred.
§ Length of exposure, proximity, and frequency 
of exposure.
§ Virulence (strength) of the tubercle bacilli.
§ Susceptibility of the exposed person.
 The best way to stop transmission is to:
§ Isolate infectious persons.
§ Provide effective treatment to infectious persons as soon as 
possible.
TB	Transmission
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TB	Pathogenesis
Droplet nuclei containing tubercle 
bacilli are inhaled, enter the lungs, 
and travel to the alveoli.
Tubercle bacilli multiply in the 
alveoli.
Alveoli are the small air sacs of the lung that are 
at the end of the airway; when droplet nuclei 
reach these air sacs, TB infection begins. 
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TB	Pathogenesis
A small number of tubercle bacilli 
enter the bloodstream and spread 
throughout the body. 
The tubercle bacilli bacteria usually
attack the lungs  but may reach any 
part of the body, including areas 
where TB disease is more likely to 
develop (such as the brain, larynx, 
lymph node, spine, bone, or kidney). 
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TB	Pathogenesis
Within 2 to 8 weeks, special immune 
cells called macrophages ingest and 
surround the tubercle bacilli. The cells 
form a barrier shell, called a granuloma, 
that keeps the bacilli contained and 
under control (LTBI).
If the immune system cannot keep the 
tubercle bacilli under control, the bacilli 
begin to multiply rapidly (TB disease). 
This process can occur in different areas 
in the body, such as the lungs, kidneys, 
brain, or bone.
USF - TB Fundamentals & Response Planning 2016 33
Symptoms
 Symptoms of TB depend on where in the body the bacteria is 
growing.
 Symptoms for TB in the lungs:
§ Bad cough that lasts 3 weeks or longer
§ Pain in the chest
§ Coughing up blood or sputum
 Other symptoms of TB disease:
§ Weakness or fatigue
§ Weight loss
§ No appetite
§ Chills
§ Fever
§ Sweating at night
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Latent	TB	Infection	(LTBI)
 Not everyone who is infected becomes sick.  This is 
called Latent TB Infection (LTBI).
 Immune system is able to “fight” the bacteria after it is 
breathed in.
 Bacteria become inactive but remain alive in the body 
and can become active later.
 Persons with LTBI:
§ Have no symptoms.
§ Do not feel sick.
§ Cannot spread TB bacteria to others.
§ Usually have a positive skin test reaction (PPD) 
or positive TB blood test (T-Spot, Quantiferon TB-Gold).
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LTBI
 Many people with LTBI never 
develop active TB disease.
§ Bacteria remain inactive for a lifetime without causing 
disease.
 In persons with weak immune systems, bacteria 
become active, multiply, and cause disease.
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Weak	Immune	Systems	Which	Can	
Lead	to	Progression	to	TB	disease
 Seen in babies and young children.
 Persons infected with HIV.
 Persons with substance abuse.
 Persons with Diabetes mellitus.
 Silicosis  (a lung disease caused by inhaling silica dust, which is 
used in the production of glass and ceramics; occurs most often in 
mining and foundry workers). 
 Cancer of the head or neck.
 Leukemia or Hodgkin’s disease.
 Severe kidney disease.
 Low body weight.
 Certain medical treatments (corticosteriod treatment or organ 
transplants).
 Specialized treatment for rheumatoid arthritis or Crohn’s disease.
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LTBI	Progression	to	TB	Disease	
 Risk of developing TB disease is highest in the 
first 2 years after infection. 
 People with LTBI can be given treatment to 
prevent them from developing TB disease.
 Detecting TB infection early and providing 
treatment helps prevent new cases of TB 
disease.
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LTBI	Progression	to	TB	Disease	
People Exposed to TB
Not	
TB	Infected
Latent TB 
Infection (LTBI)
Not 
Infectious
Positive TST or 
QFT-G test result
Latent TB 
Infection
May go on to 
develop TB 
disease
Not	
Infectious
Negative	TST	or	
QFT-G	test	result
No	
TB	Infection
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LTBI	vs.	TB	Disease
Person with LTBI (Infected) Person with TB Disease (Infectious)
Has a small amount of TB bacteria in his/her 
body that are alive, but inactive.
Has a large amount of active TB bacteria in 
his/her body.
Cannot spread TB bacteria to others. May spread TB bacteria to others.
Does not feel sick, may not have any 
symptoms; but may become sick if the 
bacteria become active in his/her body.
May feel sick and may have symptoms such 
as fever, and/or weight loss, bad cough that
lasts 3 weeks or longer, pain in chest, 
coughing up blood or sputum, weakness or 
fatigue, no appetite, chills, sweating at night.
Usually has a TB skin test or TB blood test 
reaction indicating TB infection.
Usually has a TB skin test or TB blood test 
reaction indicating TB infection.
Radiograph is typically normal (normal chest x-
ray).
Radiograph may be abnormal.
Sputum smears and cultures are negative. Sputum smears and cultures may be positive.
Should consider treatment for LTBI to prevent 
TB disease.
Needs treatment for TB disease.
Does not require respiratory isolation. May require respiratory isolation.
Not a TB case. A TB case.
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Persons	at	Higher	Risk	for	Exposure	to	
or	Infection	with	TB	
 Spent time with a person known or suspected 
to have active TB disease (close contact).
 Persons from a country where active TB disease 
is very common (most countries in Latin America,
Caribbean, Africa, Asia, Eastern Europe, Russia)
– foreign-born.
 Persons who have lived or worked somewhere in the US 
where active TB disease is more common (homeless shelter, 
migrant farm camp, prison, jail, nursing home) – congregate 
settings.
 Health care workers (HCWs) who serve high-risk clients.
 Children and adolescents exposed to adults at increased risk 
for infection or disease.
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Persons	at	Higher	Risk	for	Exposure	to	
or	Infection	with	TB
 Persons who visit TB-prevalent 
countries.
 Populations defined locally as having increased 
incidence of latent M. tuberculosis infection or TB 
disease, such as medically underserved, low-income 
persons, and persons who inject illegal drugs or abuse 
drugs or alcohol.
 Persons who have HIV infection or another condition that 
weakens the immune system.
§ Persons co-infected with HIV and M. tuberculosis are 
more likely to develop TB disease. 
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TB	and	HIV
People who are infected with both M. tuberculosis and 
HIV are much more likely to develop TB disease.
TB infection
and NO risk factors
TB infection 
and HIV infection 
(pre-Highly Active Antiretroviral 
Treatment [HAART])
Risk is about 5% in the first 
2 years after infection and 
about 10% over a lifetime.
Risk is about 7% to 10% 
PER YEAR, a very high 
risk over a lifetime.
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In an HIV-infected person, TB can develop in one of
two ways:
 Person with LTBI becomes 
infected with HIV and then 
develops TB disease as the 
immune system is weakened.
 Person with HIV infection 
becomes infected with 
M. tuberculosis and then rapidly develops TB 
disease.
TB	and	HIV
Image	credit:	Mississippi	State	Department	of	Health
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 Caused by M. tuberculosis organisms resistant to 
at least one TB treatment drug: 
 Isoniazid (INH)
 Rifampin (RIF)
 Pyrazinamide (PZA)
 Ethambutol (EMB)
 Resistant means drugs can no longer kill the bacteria.
 Transmitted in the same way as drug-susceptible TB and 
is no more infectious.
 Delay in detecting drug resistance may prolong period of 
infectiousness because of delay in starting the right 
treatment.
Drug-Resistant	TB	
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Primary 
Resistance
Caused by person-to-person 
transmission of drug-resistant 
organisms.
Secondary 
Resistance
Develops during TB treatment:
• Patient was not given appropriate 
treatment regimen.
OR
• Patient did not follow treatment 
regimen as prescribed.
Drug-Resistant	TB
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Mono-resistant Resistant to any one TB treatment drug.
Poly-resistant Resistant to at least any 2 TB drugs 
(but not both isoniazid and rifampin).
Multi-drug 
resistant 
(MDR TB)
Resistant to at least isoniazid and 
rifampin, the 2 best first-line TB 
treatment drugs.
Extensively 
drug-resistant 
(XDR TB)
Resistant to isoniazid and rifampin, 
PLUS resistant to any fluoroquinolone 
AND at least 1 of the 3 injectable 
second-line drugs (e.g., amikacin, 
kanamycin, or capreomycin).
Drug-Resistant	TB
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 MDR TB has decreased in foreign-born and U.S.born
persons, but the decline is greater in U.S.born.
 1993–2011, proportion of primary MDR TB in foreign-
born increased from 25% to 83%.
MDR TB*
with drug resistance 
to at least the first-
line drugs isoniazid 
and rifampin
TB 
with any
drug 
resistance
XDR TB**
with drug resistance
to the first-line drugs  
isoniazid and rifampin and 
to specific second-line 
drugs
*Often resistant to additional drugs.
**Resistant to any fluoroquinolone and at least one of three injectable second-line drugs  (i.e., amikacin, kanamycin, or capreomycin).
Drug-Resistant	TB
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Risk of drug-resistant TB is increased with exposure to 
a person who:
 Has confirmed drug-resistant TB.
 Had prior unsuccessful treatment
for TB, and drug susceptibility 
results are not known.
 Originated in a drug-resistant TB-prevalent country.
 Has positive smear and culture 2 months after 
treatment start.
Drug-Resistant	TB
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 XDR TB is a rare type of MDR TB.
§ Resistant to INH, RIF, fluoroquinolones, and ≥1 of 3 
injectable 2nd-line drugs.
 No apparent trend for XDR TB in the U.S.
Drug-Resistant	TB
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Methods	for	Detecting	M.	tb Infection	
in	U.S.
• Mantoux tuberculin skin test (TST): 
§ TB Skin Test, PPD
• IGRAs: (Blood Tests)
§ QuantiFERON-TB Gold In-Tube (QFT-GIT)®, and
§ T-Spot.TB®
• These tests do not exclude LTBI or TB disease.
• Decisions about medical/public health management 
should include other info/data, and not rely only on 
TST/IGRA results.
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Identifying	High-Risk	Groups	for	M.	tb
Testing
 Health-care providers should find 
and test: 
§ Uninfected persons at high risk 
for LTBI, and/or
§ Persons at high risk for progression to TB disease.
 Flexibility needed in defining high-risk groups.
§ Risk for TB or LTBI in current high-risk groups may 
decrease over time, and groups currently not at risk 
may subsequently become high risk.
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Evaluation	of	Persons	with	Positive	TB	
Tests
 Facilities should consult with local health
department before starting testing 
program to ensure evaluation and 
treatment resources are available.
 Persons with positive TST or IGRA should be 
evaluated for disease.
 If disease is ruled out, consider for LTBI treatment.
 If patient not willing or able to take treatment, 
educate on TB signs and symptoms.
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Mantoux Tuberculin	Skin	Test	(TST)
 Purified protein derivative (PPD), derived from 
tuberculin, is injected between skin layers using the 
Mantoux technique.
 Infected person’s immune cells recognize TB 
proteins in PPD, respond to site, causing wheal to 
rise.
 Takes 2-8 weeks after exposure and infection for 
the  immune system to react to PPD.
 Reading and interpretation of TST reaction must be 
done within 48–72 hours.
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Administering	the	TST
 Inject 0.1 ml of PPD (5 tuberculin units) into forearm 
between skin layers. 
 Produce wheal (raised area) 6–10 mm in diameter.
 Follow standard precautions for infection control.
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Reading	the	TST
 Trained health care worker assesses reaction 
48–72 hours after injection.
 Palpate (feel) injection site to find raised area.
 Measure diameter of induration across forearm; 
only measure induration, not redness.
 Record size of induration in millimeters; record 
“0” if no induration found.
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Interpreting	the	TST	Reaction
≥5 mm induration is classified as positive in:
 HIV-infected persons.
 Recent contacts of infectious TB.
 Persons with fibrotic changes on chest radiograph 
consistent with prior TB.
 Patients with organ transplants and other 
immunosuppressed patients.
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Interpreting	the	TST	Reaction
≥10 mm induration is classified as positive in:
 Recent arrivals from high-prevalence countries.
 Injection drug users.
 Residents and employees of high-risk congregate 
settings.
 Mycobacteriology laboratory personnel.
 Persons with conditions that increase risk for 
progressing to TB.
 Children <5 years of age, or children and youth 
exposed to adults at high risk.
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Interpreting	the	TST	Reaction
≥15 mm is classified as positive in:
 Persons with no known risk factors for TB.
NOTE: Targeted skin testing should only be conducted 
among high-risk groups.
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Factors that can cause people to 
have a positive reaction even if 
they do not have TB infection:
• Infection with nontuberculous mycobacteria.
• BCG vaccination.
• Administration of incorrect antigen.
• Incorrect measuring or interpretation of TST reaction.
Mantoux Tuberculin	Skin	Test	
False-Positive	Reaction
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Factors that can cause false-negative reactions:
• Anergy (absence of a reaction).
• Viral, bacterial, fungal co-infection.
• Recent TB infection (within past 8 – 10 weeks).
It can take 2 – 8 weeks after TB infection for body’s immune system to react to tuberculin.
• Younger than 6 months of age, advanced age.
• Recent live-virus (e.g., measles or smallpox) vaccination.
• Incorrect method of giving the TST.
• Incorrect measuring or interpretation of TST reaction.
• Overwhelming TB disease.
• Renal failure/disease.
• Lymphoid disease.
• Low protein states.
• Immunosuppressive drugs.
Mantoux Tuberculin	Skin	Test	
False-Negative	Reaction
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Special	Considerations	When	Using	TST
Boosting:
 Some may have negative (waned) 
TST reaction when tested years 
after infection (e.g., older adults).
 Initial skin test may stimulate 
(boost) ability to react to PPD.
 Subsequent positive boosted reaction may be 
misinterpreted as a new infection.
 May still be considered for treatment if currently at high 
risk for TB disease.
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Special	Considerations	When	Using	TST
Two-Step Testing:
 Used for initial skin testing of adults 
to be retested periodically, to reduce 
likelihood that boosted reaction will be 
misinterpreted as recent infection.
 If 1st test positive, consider infected; if negative, give 2nd 
test 1–3 weeks later.
 If 2nd test positive, consider infected; if negative, 
consider uninfected.
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Special	Considerations	When	Using	TST
Pregnant women:
 TST is safe and reliable for 
mother and fetus throughout pregnancy.
 Give TST to pregnant women who have risk factors 
for infection or disease. 
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Special	Considerations	When	Using	TST
Occupational Exposure to TB:
 Cutoff for defining a positive TST 
reaction depends on:
§ Individual risk factors for TB.
§ Prevalence of TB in the facility.
 High-risk sites should test residents and staff at entry 
and hire and at intervals determined by annual risk 
assessment.
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Interferon	Gamma	Release	Assays	
(IGRAs)
 IGRAs detect M. tb infection by 
measuring immune response in blood.
 Cannot differentiate between TB and LTBI; other 
tests needed.
 May be used for surveillance/screening, or to find 
those who will benefit from treatment.
 FDA-approved IGRAs are QFT Gold In-Tube and T-
Spot.TB test.
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Types	of	IGRAs
• QuantiFERON®-TB Gold (QFT-G)
§ CDC guidelines published in 
2005
• QuantiFERON®-TB Gold In-Tube 
(QFT-GIT)
§ Approved 10/2007
• T-Spot®.TB test (T-SPOT)
§ Type of ELISpot assay
§ Approved 7/2008
T-Spot®.TB test Materials
Image Credit: U.S. Food and Drug 
Administration (FDA), 2009
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General	Recommendations	for	Using	
IGRAs
 May be used in place of, 
but not in addition to, TST.
 Preferred when testing persons:
§ Who might not return for TST reading.
§ Who have received BCG vaccination.
 Generally should not be used to test children <5 
years of age, unless used in conjunction with TST.
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General	Recommendations	for	Using	
IGRAs
May be used in place of TST to test recent contacts 
of infectious TB.
 Detect M. tb infection with greater specificity than 
TST.
 Data are limited on ability to predict subsequent 
TB.
 In contact investigations, confirm negative via 
retest 8–10 weeks post-exposure.
 Use same test for repeat testing to reduce 
misclassification errors.
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General	Recommendations	for	Using	
IGRAs
 May be used for periodic 
screening, e.g., for health-care 
workers.
 IGRAs do not boost subsequent test results; 
administered with one patient visit.
 Results from both IGRA and TST may be useful 
when initial test is:
§ Negative, and patient has high risk of TB infection or 
disease.
§ Positive, and additional evidence is required/desired.
§ Unclear or indeterminate.
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QFT-G	and	QFT-GIT	
Conducting	the	Test
 Follow manufacturer’s instructions.
 Confirm arrangements for delivery and testing of blood 
within 12 hours of collection.
 Draw sample of blood into tube with heparin.
 Schedule appointment for patient to receive test 
results.
§ If needed, schedule medical evaluation and 
treatment for LTBI or TB disease.
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 Blood samples are mixed with antigens and 
incubated for 16 - 24 hours.
 If infected with M. tuberculosis, blood cells will 
recognize antigens and release interferon 
gamma (IFN-γ) in response.
 Results are based on the amount of IFN-γ 
released in response to antigens and control 
substances.
QFT-G	and	QFT-GIT	
How	it	Works
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QFT-G	and	QFT-GIT	
Interpreting	Results
 Test results are based 
on IFN-γ 
concentrations.
 Laboratories can use 
software provided by 
manufacturer to 
calculate results.
 Results are sent to 
requesting clinician.
Processing QFT-G Sample
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QFT-G	and	QFT-GIT	
Report	of	Results
Result Report/Interpretation
Positive M. tuberculosis infection likely
Negative
M. tuberculosis infection unlikely, but
cannot be excluded especially if:
1. Patient has TB signs and symptoms. 
2. Patient has a high risk for developing TB 
disease once infected with M. tuberculosis. 
Indeterminate
Test did not provide useful information
about the likelihood of M. tuberculosis
infection.  Options are to repeat test,
administer a TST, or do no additional
testing.
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T-SPOT
 Type of ELISpot assay.
 Interferon gamma is presented as 
spots from T cells sensitized to 
M. tuberculosis.
 Results are interpreted by subtracting the spot count 
of the control from the spot count of the sample.
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 Requires single patient visit to conduct test.
 Results can be available in 24 hours.
 Does not cause booster phenomenon.
 Less likely to have incorrect reading of results as 
compared to TST.
 BCG vaccination does not affect results.
IGRA	Advantages	
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 Blood samples must be processed 
within 12 hours for some IGRAs.
 Errors in running and interpreting 
test can decrease accuracy. 
 Limited data on its use in certain populations.
 Limited data on its use to determine who is at risk for 
developing TB disease.
IGRA	Disadvantages	and	Limitations
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BCG	Vaccination
 Vaccine made from live, 
attenuated (weakened) strain of 
M. bovis.
 Early version first given to humans 
in 1921.
 Many TB-prevalent countries vaccinate infants to prevent 
severe TB disease.
 BCG not generally recommended in the U.S.
 However, its use may be considered in very limited 
circumstances.
 Use BCG only after consultation with local health 
department and TB experts.
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Recommendations	for	BCG	Vaccination
Infants and Children:
 Can be considered for infant or 
child with negative skin-test result 
who:
§ Is continually exposed to untreated or ineffectively 
treated adult.
§ Will be continually exposed to adult with MDR TB.
 BCG vaccination not recommended for HIV-
infected children.
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Recommendations	for	BCG	Vaccination
Health-Care Workers:
Should be considered on individual 
basis for health-care workers in 
settings in which:
 A high percentage of MDR TB patients has been 
found.
 Transmission of drug-resistant TB strains and 
subsequent infection are likely, and
 Comprehensive TB infection-control precautions 
have been implemented but not successful.
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BCG	Contraindications
Contraindicated in persons with impaired immune 
response from:
• HIV infection, congenital immunodeficiency
• Leukemia, lymphoma, generalized malignancy
• High-dose steroid therapy
• Alkylating agents
• Antimetabolites
• Radiation therapy
Note: BCG vaccination should not be given to 
pregnant women. 
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Interpretation	of	TB	Test	Results	in	
BCG-Vaccinated	Persons
Results used to support or exclude diagnosis of 
infection.
 TST or IGRA not contraindicated for BCG-vaccinated 
persons.
 In BCG-vaccinated, interpret TST with same criteria 
used for non–BCG-vaccinated.
 Booster phenomenon may occur in BCG-vaccinated 
persons.
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Exercise	1:	Screening
For this activity, group persons from 
similar/same organizations together.
 Using the protocol template, consider what you have 
learned so far. 
 How would your organization identify a single case 
of TB?
 Record your responses on the flip chart.
§ Use the smaller template for your notes.
 The next slide shows you an example of how to 
complete the template.
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Creation	of	Protocols-Screening:	
Identifying	Single	Cases
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Exercise	1:	Screening
Now that your team has recorded your template 
responses on the flip chart, rotate as a team 
clockwise and review how other teams have 
responded.
 Do you understand each step in their protocol?
§ If NOT, use a colored sticky note to let the team know what needs to 
be further clarified.
 Is there an additional Action, Lead, Experience, Resources, 
Timeframe, Achievement Review, or Review Date the team 
should add?
§ Add additional information in a different color marker to the flip chart.  
 Conduct this review for each team until you are back to your 
starting team flip chart. 
§ Review the critiques of the other teams, and incorporate any of the 
recommendations that your team deem appropriate. 
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Diagnosis & Reporting of 
Tuberculosis
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Sites	of	TB	Disease	
Bacilli may reach any part of the body, but common
sites include:
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Sites	of	TB	Disease	
Location Frequency
Pulmonary TB Lungs Most TB cases are 
pulmonary
Extrapulmonary TB Places other than 
lungs such as:
• Larynx
• Lymph nodes
• Pleura
• Brain
• Kidneys
• Bones and joints
Found more often in:
• HIV-infected or
other
immunosuppressed
persons
• Young children
Miliary TB Carried to all parts of 
body, through 
bloodstream
Rare
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Diagnosis	of	TB	Disease
Medical Evaluation
• Medical history
• Physical examination
• Test for TB infection
• Chest radiograph
• Bacteriologic examination
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1.		Medical	History	
Clinicians should ask patients if they have:
• General symptoms of TB disease. (how long?)
• Fever, chills, night sweats, weight loss, appetite loss, fatigue 
and malaise.
• Symptoms of pulmonary TB disease. (how long?)
• Cough lasting 3 or more weeks 
• Chest pain 
• Coughing up sputum or blood
• Exposure to a person with infectious TB or have risk factors for 
exposure to TB.
• Any risk factors for developing TB disease.
• Had LTBI or TB disease before
• Demographics (country of origin, age, ethnicity, occupation, racial 
group).
• Underlying medical conditions such as HIV or diabetes.
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Symptoms of Extrapulmonary
TB disease depend on part of 
body that is affected
• Blood in the urine (TB of the 
kidney)
• Headache/confusion (TB 
meningitis)
• Back pain (TB of the spine)
• Hoarseness (TB of the larynx)
• Loss of appetite, unexplained 
weight loss
• Night sweats, fever
• Fatigue
1.		Medical	History	
Symptoms	of	Extrapulmonary TB	Disease
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A physical examination cannot confirm or rule out
TB disease, but can provide valuable information
about the patient’s overall condition.
2.		Physical	Examination
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3.		Test	for	TB	Infection	
Types of tests available for 
diagnosing TB infection in 
U.S.:
 TST
 IGRAs
§ QFT-G
§ QFT-GIT
§ T-SPOT
QFT-G  lab kit
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3.		Test	for	TB	Infection	
Patients with symptoms of TB disease should 
always be evaluated for TB disease, regardless of 
their TST or IGRA test result.
• Clinicians should not wait for TST or IGRA results 
before starting other diagnostic tests.
• TST or IGRA should be given at the same time as 
other steps in the diagnosis of TB disease.
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4.	Chest	Radiograph
 Chest abnormalities 
suggest, but do not confirm, 
TB disease.
 Posterior-anterior view is 
standard.
 Apical/posterior areas of 
upper lobe or superior areas 
of lower lobe often show 
abnormalities.
 In immunosuppressed (e.g., 
HIV-infected), lesions may 
have atypical appearance. Chest	Radiograph	with	Lower	Lobe	Cavity
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4.	Chest	Radiograph
 Old TB can produce dense, hard nodules or lesions 
containing live bacilli.
 Fibrotic nodules/lesions from old TB + positive TB test 
= high-priority candidate for LTBI treatment. 
 Calcified lesions pose low risk for progressing to TB.
 Active versus inactive disease cannot be determined 
from chest radiograph alone.
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4.	Chest	Radiograph
 In HIV-infected patients, pulmonary 
TB may present an atypical radiograph. 
§ Less common:  Cavitary disease 
(with higher CD4 counts) 
§ More common:  Infiltrates,  adenopathy, or normal 
radiograph (with lower CD4 counts)
 With signs/symptoms, negative radiograph does not rule 
out disease.
 With no signs/symptoms and positive TB test, negative 
radiograph may rule out TB in HIV-negative person.
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5.	Bacteriologic	Examination	of	
Specimens
 Specimen collection
 AFB smear 
classification
 NAA testing
 Culture and 
identification
 Drug-susceptibility 
testing
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5.	Bacteriologic	Examination	of	
Specimens	
Specimen collection, processing, and 
review:
 All persons suspected of TB disease 
should have sputum cultured.
 Collect at least 3 sputum specimens 
at 8- to 24-hour intervals, at least 1 in 
the morning.
 Follow infection control precautions 
during specimen collection.
 Collection methods include coughing, 
sputum induction, bronchoscopy, 
gastric aspiration. 
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5.	Bacteriologic	Examination	of	
Specimens
Specimen collection methods for Extrapulmonary
TB:
 TB disease can occur in almost any site.
 Variety of clinical specimens other than sputum can 
be submitted.
 Before collection, ensure transport and processing 
procedures are in place.
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Smear examination:
 Detecting AFB in smears 
may be first evidence of 
mycobacteria.
 Quickest (results within 
24 hours) and easiest 
procedure.
 Provides a preliminary 
presumptive diagnosis of 
TB.
 AFB in a smear are 
counted and classified as 
4+, 3+, 2+, or 1+.
AFB	Smear:	AFB	(Shown	in	Red)	are	
tubercle	bacilli
5.	Bacteriologic	Examination	of	
Specimens
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Direct	Detection	Using	Nucleic	Acid	
Amplification	(NAA)
 NAA tests rapidly identify a specimen via DNA and RNA 
amplification.
 Benefits may include:
§ Earlier lab confirmation of TB disease.
§ Earlier respiratory isolation and treatment initiation.
§ Improved patient outcomes; interruption of 
transmission.
 Perform at least 1 NAA test on 
each pulmonary TB suspect.
 A single negative NAA test 
does not exclude TB.
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Culture
 Remains gold standard for 
confirming diagnosis of TB.
 Culture all specimens, even if 
smear or NAA negative.
 Results in 4–14 days when 
liquid medium systems used.
 Culture monthly until conversion, i.e., 2 consecutive 
negative cultures.
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Drug-Susceptibility	Testing
• Conduct drug-susceptibility testing on initial M. tb
isolate.
• Promptly forward results to 
the health department.
• Repeat for patients who: 
• Do not respond to therapy 
OR
• Have positive cultures despite 3 months of therapy.
USF - TB Fundamentals & Response Planning 2016 104
Second-Line	Drug-Susceptibility	
Testing
Limit to persons at increased risk for drug resistance:
 Have history of treatment with TB drugs.
 Had contact with a person with drug-resistant TB.
 Demonstrated resistance to first-line drugs.
 Have positive smears or cultures despite 3 months 
of TB treatment.
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Molecular	Detection	of	Drug	
Resistance
 Drug resistance is caused by 
mutations in specific M. tb
genes.
 Several molecular assays and tests can detect 
mutations.
 Molecular detection should be used for patients 
with high risk for rifampin resistance (MDR TB).
 Conventional drug susceptibility testing should 
be done in conjunction with molecular tests.
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Genotyping
 Laboratory-based approach that 
analyzes the genetic material of 
patient isolates.
 Different strains of M. tb have different genotype 
patterns.
 M. tb isolates with identical genotypes often 
indicates recent transmission.
 Main purpose of genotyping: add to TB 
controllers’ understanding of TB transmission in 
their community.
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Genotyping
Used with traditional epi 
investigations, genotyping has:
 Confirmed/detected transmission.
 Identified risk factors for recent infection.
 Demonstrated re-infection with different strains.
 Identified weaknesses in conventional contact 
investigations.
 Documented lab cross-contamination.
 Identified outbreaks not previously recognized.
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Classification	System	for	TB
 Based on TB pathogenesis 
(stage of disease).
 Helps clinician track the 
development of TB in 
patients.
 Persons with class 3 or 5 TB 
should be reported to health 
department.
 Patients should not have 
class 5 classification for 
more than 3 months.
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Reporting	TB	Cases	
TB programs report TB 
cases to CDC using a 
standard case report form 
called the Report of 
Verified of Case of 
Tuberculosis (RVCT).
 All cases that meet criteria 
are called verified TB 
cases.
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Criteria	for	Reporting	TB	Cases	
Cases that meet one of these four sets of criteria are counted as verified TB 
cases:
1. Patient has positive culture for M. tuberculosis.
2. Patient has positive AFB smear, but culture has not or cannot be 
done.
3. Patient has positive NAA test for M. tuberculosis.
• NAA test must be accompanied by culture for mycobacteria 
species.
4. In the absence of laboratory confirmation, patient has:
• Positive TST reaction.
• Other signs and symptoms of TB disease.
• Been treated with 2 or more TB drugs.
• Been given a complete diagnostic evaluation.
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Criteria	for	Reporting	TB	Cases	
Cases that do not meet any of these sets of criteria 
may be counted as a verified TB case if health care 
provider has decided to treat the patient for TB 
disease.
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Report	of	Verified	Case	of	
Tuberculosis	(RVCT)	Pages	1-3
USF - TB Fundamentals & Response Planning 2016 113
Report	of	Verified	Case	of	
Tuberculosis	(RVCT)	Pages	4-6
RVCT is completed by the TB Controller to report cases to CDC.  
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Exercise	2:	Determine	the	
Infectiousness	of	Case	Scenario
 The next series of slides are case studies.
 Working in groups of 2-3 persons, utilize the 
information you have learned in the last 2 sections to 
determine the infectiousness of each case.  
 Present your decisions on actions to the larger 
group.
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Case	Study	1
A 32-year-old man needs a TST 
because he is required to have one 
before starting his new job as a health 
care worker. He has an 18mm positive reaction to 
the TST. He has no symptoms of TB, and his chest 
x-ray findings are normal.  He was born in China but 
has been in the U.S. for 15 years.
Should this be considered a case of TB? 
Should this man be considered infectious?  
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Case	Study	1	Answer
Should this be considered a case of TB? 
No. The man described above has TB infection. 
He has an 18mm positive reaction to TST, but no 
evidence of TB disease. Therefore, this is not a 
case of TB. 
Should this man be considered infectious? 
No, he should not be considered infectious. This 
man has LTBI, not TB disease. People with TB 
infection and no evidence of TB disease are not 
infectious. 
Case	Study	2
A 45-year-old woman is referred to 
the health department by her private
physician because she was found to
have LTBI as part of an employee testing program. 
She is obese, with high blood pressure. Upon 
further questioning, she reports that she has 
injected illegal drugs in the past but has never been 
tested for HIV infection. 
What conditions does this woman have that 
increase the risk that she will develop TB 
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Case	Study	2	Answer
What conditions does this woman have that 
increase the risk that she will develop TB 
disease? 
Injection of illegal drugs increases the risk that 
LTBI will progress to TB disease. This woman 
may also be at risk for HIV infection, which is the 
strongest known risk factor for developing TB 
disease. This woman should be offered HIV 
counseling, testing, and referral. Obesity and 
high blood pressure are NOT risk factors for TB 
disease.
Case	Study	3
Which of the following patients have a 
positive tuberculin skin test reaction?
a. Mr. West, 36 yrs. old, HIV infected, 8 mm induration.
b. Ms. Hernandez, 26 yrs. old, native of Mexico, 
7 mm induration.
c. Ms. Jones, 56 yrs. old, diabetic, 12 mm induration.
d. Mr. Sung, 79 yrs. old, nursing home resident, 
11 mm induration.
e. Mr. Williams, 21 yrs. old, no known risk factors, 
13 mm induration.
f. Mr. Marcos, 42 yrs. old, chest x-rays findings suggestive of 
previous TB, 6 mm induration.
g. Ms. Rayle, 50 yrs. old, husband has pulmonary TB, 
9 mm of induration.
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Case	Study	3	Answer
Which of the following patients have a positive tuberculin 
skin test reaction?
a. Mr. West, 36 yrs. old, HIV infected, 8 mm induration
b. Ms. Hernandez, 26 yrs. old, native of Mexico, 
7 mm induration
c. Ms. Jones, 56 yrs. old, diabetic, 12 mm induration
d. Mr. Sung, 79 yrs. old, nursing home resident, 
11 mm induration
e. Mr. Williams, 21 yrs. old, no known risk factors, 
13 mm induration
f. Mr. Marcos, 42 yrs. old, chest x-rays findings suggestive of 
previous TB, 6 mm induration
g. Ms. Rayle, 50 yrs. old, husband has pulmonary TB, 
9 mm of induration
Case	Study	4
A 30 year-old man who recently 
immigrated from India is given a TST 
and found to have 14mm of induration.  
He reports that he was vaccinated with BCG as a 
child.  He also says that his wife was treated for 
pulmonary TB disease last year.
How should this man’s results be interpreted?
What factors make it more likely that this man’s 
positive reaction is due to TB infection?
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Case	Study	4	Answer
How should this man’s results be interpreted?
 Positive reaction to TST
 Should be further evaluated for LTBI or TB 
disease
What factors make it more likely that this man’s 
positive reaction is due to TB infection?
 From area of the world where TB is common
 Wife had pulmonary TB
Case	Study	5
Mr. Bell comes to the TB clinic for a TST. 
He believes that he has been exposed 
to TB, and he knows he is at high risk for 
TB because he is HIV-infected.  He is given a TST, 
and his reaction is read 48 hours later as 0 mm of 
induration.
What are 3 ways to interpret this result?
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Case	Study	5	Answer
What are 3 ways to interpret this result?
May not have TB infection
May be anergic
 It may be less than 8–10 weeks since 
he was exposed to TB.
Case	Study	6
Ms. Wilson is a 60-year-old nurse.  
When she started a job at the local 
hospital, she was given a TST, her first 
test in 25 years.  Her reaction was read 
48 hours later as 0 mm induration.  Six months 
later, she was re-tested as part of the TB testing 
program in the unit where she works.  Her skin test 
reaction was read 48 hours later as 11 mm of 
induration. 
What are 2 ways to interpret this result?
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Case	Study	6	Answer
What are 2 ways to interpret this result?
She was exposed to TB sometime in the 
6 months between her first and second 
skin tests.
Booster phenomenon
Case	Study	7
Mr. Lee has a cough and other 
symptoms of TB disease, and he is 
evaluated with a chest x-ray.  
However, he is unable to cough up 
any sputum on his own for the 
bacteriologic examination.
What should be done?
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Case	Study	7	Answer
What should be done?
Other techniques can be used to obtain 
sputum.  First, clinicians can try to 
obtain an induced sputum sample.  If 
they cannot obtain the sample, a 
bronchoscopy or gastric washing may 
be done.
Case	Study	8
Ms. Thompson gave three sputum 
specimens, which were sent to the 
laboratory for smear examination and 
culture. The smear results were 
reported as 4+, 3+, and 4+.
What do these results tell you about Ms. 
Thompson’s diagnosis and her infectiousness?
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Case	Study	8	Answer
What do these results tell you about  Ms. 
Thompson’s diagnosis and her infectiousness?
 Results show that Ms. Thompson’s sputum 
specimens contain many acid-fast bacilli. 
 Smears are positive; clinicians should suspect 
that she has TB disease and should consider 
her infectious.
 It is possible that the AFB are mycobacteria 
other than tubercle bacilli.  
 Diagnosis cannot be proven until culture results 
are available.
Case	Study	9
Mr. Sagoo has symptoms of TB disease 
and a cavity on his chest x-ray, but all of 
his sputum smears are negative for 
acid-fast bacilli.
Does this rule out the diagnosis of pulmonary TB 
disease?
Why or why not?
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Case	Study	9	Answer
Does this rule out the diagnosis of pulmonary TB 
disease?
No.
Why or why not?
M. tuberculosis may grow in the cultures 
even though there were no acid-fast 
bacilli on the smear.  Mr. Sagoo’s
symptoms and his abnormal chest x-ray 
suggest that he does have pulmonary TB 
disease.
Case	Study	10
In the public health clinic, you 
see a patient, Ms. Sanchez, 
who complains of weight loss, 
fever, and a cough of 4 weeks’ 
duration.  When questioned, she reports that she 
has been treated for TB disease in the past and 
that she occasionally injects heroin. 
What parts of Ms. Sanchez’s medical history 
lead you to suspect TB disease?
What diagnostic tests should be done?
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Case	Study	10	Answer
What parts of Ms. Sanchez’s medical history 
lead you to suspect TB disease?
 Symptoms of TB disease (weight loss, fever, 
persistent cough)
 Past treatment for TB disease
 History of injecting illegal drugs
What diagnostic tests should be done?
 Chest x-ray
 Sputum smear and culture
 Drug susceptibility testing
Exercise	3:	Suspect	TB	Case	
For this activity, group persons from 
similar/same organizations together.
 Using the protocol template, consider what you 
have learned in the third section. How would 
your organization handle a suspect TB case? 
 Record your responses on the flip chart.
§ Use the smaller template for your notes.
 The next slide shows you an example of how to 
complete the template.
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Creation	of	Protocol	-
Managing	Suspect	TB	Case
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Exercise	3:	Suspect	TB	Case
Now that your team has recorded your template 
responses on the flip chart, rotate as a team clockwise 
and review how other teams have responded.
 Do you understand each step in their protocol?
§ If NOT, use a colored sticky note to let the team know what needs to be 
further clarified.
 Is there an additional Action, Lead, Experience, Resources, 
Timeframe, Achievement Review, or Review Date the team 
should add?
§ Add additional information in a different color marker to the flip chart.  
 Conduct this review for each team until you are back to your 
starting team. 
§ Review the critiques of the other teams, and incorporate any of the 
recommendations that your team deem appropriate. 
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Tuberculosis Contact 
Investigation
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Contact	Investigation	Defined
A  contact investigation is a procedure 
for:
• Identifying people who were exposed to 
someone with infectious TB disease. 
• Evaluating these people for latent TB infection (LTBI) and 
TB disease. 
• Providing appropriate treatment for those with LTBI and 
TB disease. 
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Contact	Investigation
 People exposed to someone with infectious TB 
disease are called the contacts of that person. 
 Exposure to TB is time spent with or near such 
a person and is determined by the duration, 
proximity, and intensity of time spent with the 
person. 
 Contacts generally include family members, 
roommates or housemates, close friends, 
coworkers, classmates, and others. 
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Contact	Investigation
 Health care workers usually identify contacts by 
interviewing the person who has TB and by visiting 
the places where that person spends time regularly.
 Contacts are often given a medical evaluation and 
may receive treatment for LTBI or TB disease. 
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Contact	Investigation
A contact investigation is important in order to find 
contacts who: 
 Have TB disease so that they can be given 
treatment and further transmission can be stopped. 
 Have LTBI so that they can be given treatment for 
LTBI. 
 Are at high risk of developing TB disease and may 
need treatment for LTBI until it becomes clear 
whether they have TB infection. 
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Contact	Investigation
 Data indicate that 7-8 
cases of TB disease 
are found for every 1000 
contacts who are evaluated. 
 The rate of having TB 
disease is 75 times higher 
among contacts than among 
the general population. 
 Contact investigation allow the ability to find infected 
contacts who do not yet have TB disease, so that they 
can be given treatment for LTBI.
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Contact	Investigation
 On average, about 20% of contacts are found to 
have TB infection.
 In some contact investigations as many as 80%-
100% of the close contacts may be infected. 
 Effective contact investigations can interrupt 
transmission and prevent cases of diseases by:
§ Finding contacts of an infectious case.
§ Testing contacts of an infectious case.
§ Having infected contacts begin and complete a 
regimen of treatment for LTBI.
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Contact	Investigation	- High-Risk	
Contacts
High-risk contacts are contacts 
who are at a particularly high risk of 
developing TB disease if they have 
become infected with M. tuberculosis. 
High-risk contacts include those who:
§ Are less than 4 years of age.
§ Are immunosuppressed, e. g., infected with the human 
immunodeficiency virus (HIV).
§ Have certain other medical conditions.
§ Should be given treatment for LTBI until it becomes 
clear whether they have actually been infected. 
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When	Is	a	Contact	Investigation	Done?
 A patient (index case) is found to have or is 
suspected of having infectious TB disease. 
 TB is confirmed or there is a high clinical 
suspicion of TB.
 Strong clinical suspicion refers to a patient with 
symptoms and radiographic findings consistent 
with TB disease (and no other diagnosis to 
account for these findings). 
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When	is	a	Contact	Investigation	Done?	
 Young children with TB disease are rarely infectious, so a contact 
investigation is generally not conducted for them. However, young 
children with pulmonary TB disease should be evaluated for 
infectiousness and contact investigation may be warranted in some 
circumstances. A source case investigation should be conducted. 
 Contact investigations are not performed for diseases caused by 
nontuberculous mycobacteria. 
 Contact investigations are NOT done:
§ When index case has extrapulmonary TB, with no risk of transmission.
§ Index case has disease caused by nontuberculous mycobacterium only (e.g.,
M. avium).
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Contact	Investigation	- Source	Patient
 A source patient is a person with infectious TB 
disease who is responsible for transmitting M. 
tuberculosis to another person or persons. 
 He or she is identified through either a contact or 
source case investigation and may or may not be an 
index patient. 
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Contact	Investigation	- Source	Case	
Investigation
In some situations, a Source Case Investigation is 
conducted to find the source of TB transmission 
when recent transmission is likely. This is usually 
done when: 
• A young child is found to have TB infection or disease. 
• A severely immunosuppressed person who does not 
have a known history of TB infection is found to have TB 
disease. 
• A cluster of tuberculin skin test conversions is found in a 
high-risk institution (for example, health care or 
correctional facility). 
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Contact	Investigation	- Source	Case	
Investigation
The purpose of a Source Case Investigation is to 
determine: 
• Who transmitted M. tuberculosis to the child, index 
patient, or persons in the cluster of skin test 
conversions. 
• Whether this person is still infectious. 
• Whether the case of TB in this person was reported to 
the health department. 
• Whether any others were infected by the source 
patient. 
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Prioritizing	Contact	Investigations
If resources are limited, priority 
should be placed on identifying 
contacts and conducting follow-up 
with contacts: 
• Who are exposed to the TB patients that are 
most likely to be infectious.
• Who are at the highest risk for TB infection or TB 
disease.
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Timeframe	
 A contact investigation should begin 
as soon as TB is diagnosed or strongly 
suspected in a patient. 
 The contact investigation interview should be 
initiated no more than 3 working days after the 
case is reported to the health department. 
 Close contacts should be examined within 7 
working days after the index case has been 
diagnosed. 
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Timeframe	
A prompt contact investigation is important 
because:
 Some contacts, such as young children or HIV-infected 
and other immunosuppressed contacts, may develop TB 
disease very quickly after being exposed to and infected 
with M. tuberculosis.
 High-risk contacts need timely treatment if they have been 
infected so they will not become ill with TB disease. 
 Contacts may become harder to locate as time elapses 
(e.g., homeless, migrant workers).
 Promptness increases the likelihood that all contacts will 
be found and evaluated.
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Who	Is	Responsible	for	a	Contact	
Investigation?
• The health department is legally responsible for ensuring 
that a complete contact investigation is done for the TB 
cases reported in its area. This includes: 
§ Identifying and evaluating contacts. 
§ Treating any contacts found to have TB disease. 
§ Offering treatment for LTBI to infected contacts. 
§ Monitoring adherence to prescribed regimens and 
ensuring a system is in place to assess completion of 
treatment. 
BUT, some steps may be performed by people outside the 
health department, under the supervision of the health 
department.
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Assistance	with	Contact	Investigation
 If TB patient is in a hospital, infection control and 
employee health staff from the hospital may 
evaluate staff and some patients who were 
exposed.
 The health department will:
§ Evaluate contacts outside the institutions
§ Work with the institution to plan the investigation
§ Receive report of the results (e.g. number of contacts 
identified, number of newly documented infections, 
number of TB disease, detailed treatment plans, 
documentation of therapy administered and 
completed. 
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Steps	of	a	Contact	Investigation
1. Medical record review 
2. Patient interview 
3. Field investigation 
4. Risk assessment for M. tuberculosis
transmission 
5. Decision about priority of contacts 
6. Evaluation of contacts 
7. Treatment and follow-up for contacts 
8. Decision about whether to expand testing 
9. Evaluation of contact investigation activities 
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Step	1:	Medical	Record	Review
 Determine if and when the patient/case is infectious.
 Collect the following information on the patient/case:
§ Site of TB disease
§ TB symptoms and approximate date symptoms began 
§ Sputum smear and culture results, including the dates of 
specimen collection 
§ Results of nucleic acid amplification testing (if available) 
§ Chest x-ray results and date 
§ TB treatment (medications, dosage, and date treatment 
was started) 
§ Method of treatment administration (DOT or self-
administered) 
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Step	1:	Medical	Record	Review
For suspected cases, also collect:
 Medical risk factors that may 
increase the risk for development 
of TB disease. 
 History of tuberculin skin test results. 
 History of previous treatment for TB disease or 
TB infection. 
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Step	1:	Medical	Record	Review
Note that patients are more likely to 
be infectious if they: 
• Have pulmonary or laryngeal 
TB.
• Are coughing (especially if they 
are producing a lot of sputum).
• Have positive sputum AFB 
smear results and a positive 
culture for M. tuberculosis.
• Have chest x-ray results showing 
a cavity in the lung.
• Have had no treatment or have 
recently started treatment. 
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Step	1:	Medical	Record	Review
 Determine the period of infectiousness (the time 
period during which a person with TB disease is 
capable of transmitting M. tb).
 There is no universal, well-established method to 
establish this period.
§ It should be done by clinical and supervisory staff after 
a complete assessment of the information available. 
§ Usually done by determining the date of onset of 
patient symptoms (especially coughing).
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Step	1:	Medical	Record	Review
 The period of infectiousness ends when all the 
following criteria are met: 
§ Symptoms have improved. 
§ The patient has been receiving 
adequate treatment for at least 2 to 
3 weeks. 
§ The patient has had three consecutive 
negative sputum smears from sputum 
collected on different days. 
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Step	2:	Patient	Interview
 The initial interview should occur 
no more than 3 working days
after the case is reported to the 
health department. 
 If TB is diagnosed in the hospital, the health care 
worker should visit the patient in the hospital 
before the patient is discharged. 
 Health care workers should remember to follow 
infection control precautions while visiting a 
potentially infectious TB patient. These 
precautions may include wearing a personal 
respirator. 
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Step	2:	Patient	Interview
For a contact investigation, there are three main 
reasons to interview the TB patient: 
 To find out more about the patient's symptoms to help 
determine the period of infectiousness. 
 To find out places where the patient spent time while he or 
she was infectious. 
 To identify:
§ The patient's contacts
§ Locating information for the contacts
§ How often and how long the contacts were exposed to the 
patient while he or she was infectious. 
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Step	2:	Patient	Interview
 Symptoms: 
§ Did you have any cough? 
§ When did it begin?
 Places: 
§ Describe your daily routine? 
§ Tell me about all the places you have been since 
symptoms began.  
§ Where did you spend most of your time?  
§ Ask about - Household and residence, work or school, and 
leisure or recreation environments, places of worship, 
restaurants, etc. 
 Contacts: 
§ Names of people spent time with at each of the places identified, 
§ People the patient sees everyday or shares sleeping 
space 
§ The location of contact (where each contact can be 
found).    
Note: The patient may be reluctant to give you some 
or all of this information.  The interviewer needs to be sensitive to this 
and be ready to educate on the importance of testing contacts and to 
assure confidentiality for both the patient and the contacts. 
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Step	2:	Patient	Interview
 If a patient dies, can’t be located, or is psychologically unfit 
for an interview, it is still important to conduct a contact 
investigation.
§ Interview a proxy for the patient, such as a member of the 
patient’s household or another person knowledgeable about 
the places where the patient may have been.
§ If the interviewer knows some of the places the patient might 
have been, begin the investigation at that place (e.g., 
homeless shelter - begin with shelter management).
 There are situations where information must be revealed 
about a case without permission in order to protect public 
health.   
§ Consult appropriate supervisor or TB controller to obtain 
approval to breach confidentiality. 
§ Document in patient record. 
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Step	2:	Patient	Interview
There are several strategies for conducting successful 
effective interviews. Here is a list that an interviewer 
should use:
 Explain to the patient the importance of the contact 
investigation for preventing and controlling TB. 
 Ensure that the interview takes place under conditions that encourage 
effective communication. 
 Establish the foundation for a good relationship with the patient based 
on mutual trust and understanding. 
 Begin an assessment of the patient's knowledge, feelings, and beliefs 
about TB and educate the patient. 
 Ask open-ended questions. 
 Have a clear understanding of the interview's objectives. 
 Plan the interview so that each objective is given adequate time. 
 Listen to the patient's concerns about TB and its treatment. 
 Share information freely with the patient. 
USF - TB Fundamentals & Response Planning 2016 168
Step	2:	Patient	Interview
Open-ended questions 
are a starting point. 
The interviewer should 
ask more questions about 
names and locations of 
contacts.
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Step	2:	Patient	Interview
At the completion of the interview: 
• Decide who will notify the contacts - some TB patients 
prefer to notify contacts themselves (make sure they 
have a timeframe for completing this). 
• Reassure patient about confidentiality.
• Identify potential barriers to the contacts complying with testing by 
discussing with patient (e.g., contact does not drive-so may not be able 
to get to the health department for testing).
• Understand that the patient may not be able to recall all the names of 
possible contacts at the initial interview.
§ Provide opportunity to advise on other contacts as they remember 
them (e.g., encourage telephone calls to the interviewer as they 
remember, schedule follow-up interview).
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Step	3:	Field	Investigation
 A field investigation means visiting the patient's 
home or shelter, workplace (if any), and the other 
places where the patient said he or she spent time 
while infectious. 
 The purpose of the field investigation is to identify 
contacts and evaluate the environmental 
characteristics of the place in which exposure 
occurred. 
 The field investigation may provide additional 
information for the risk assessment and identify 
additional contacts. 
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Step	3:	Field	Investigation
During field visits, the health care worker should: 
• Observe environmental characteristics such as room size, crowding, 
and ventilation, to estimate the risk of TB transmission. 
• Identify additional contacts (especially children) and their locating 
information, such as phone numbers and addresses. 
• Look for evidence of other contacts who may not be present at the 
time of the visit (for example, pictures of others who may live in or visit 
the house, shoes of others who may live in the house, or toys left by 
children). 
• Interview and skin test close contacts who are present and arrange 
for reading of the results. 
• Educate the contacts about the purpose of a contact investigation; the 
basics of transmission; the risk of transmitting M. tuberculosis to others; 
and the importance of testing, treatment, and follow-up for TB infection 
and disease. 
• Refer contacts who have TB symptoms to the health department for 
a medical evaluation, including sputum collection.
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Step	3:	Field	Investigation
The field investigator should:
• Remember to follow infection control 
precautions while visiting potentially 
infectious TB patients.
• Be familiar with policies and recommendations for local 
law enforcement agencies and health department 
administration about personal safety.
• Obtain current information on local high-risk areas for crime.
• Wear an identity badge with current photo.
• Work in pairs when visiting potentially dangerous areas.
• Inform someone of your itinerary and expected time of 
return, especially if you anticipate problems. 
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Step	4:	Risk	Assessment	for	
M.	Tuberculosis	Transmission
Step 4 will be based on the first 3 steps: Medical 
Record Review, Patient Interview, and Field 
Investigation.  
 Assessing risk of transmission is important to 
determine priority of contacts for testing and 
evaluation.
 The risk of transmission depends on 3 main 
factors:
§ The infectiousness of the TB patient. 
§ The environmental characteristics of each place. 
§ The characteristics of the contact's exposure.
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Step	4:	Risk	Assessment	for	
M.	Tuberculosis	Transmission
Infectiousness of the TB patient:
• Dependent upon the duration of time 
which the patient was infectious, and the estimated 
degree of infectiousness.
• Degree of infectiousness (the likelihood that 
transmission will occur) is estimated from information on 
the patient’s symptoms, sputum smear results, and 
other medical information.
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Step	4:	Risk	Assessment	for	
M.	Tuberculosis	Transmission	
Environmental characteristics
Risk of transmission in a place is dependent on the 
concentration of infectious droplet nuclei in the air.
• The greater the concentration, the more likely it is that 
transmission will occur.
• The patient’s infectiousness affects the number of 
droplet nuclei generated.
There are 3 environmental characteristics to consider when 
determining concentration:
• Size of room.
• Amount of ventilation.
• Presence of air cleaning system.
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Step	4:	Risk	Assessment	for	
M.	Tuberculosis	Transmission
Characteristics of contact’s exposure:
• Length and closeness of exposure.
• Contacts at higher risk are those that frequently 
spend a lot of time with the patient and have been 
physically close to the patient.
Close contacts are persons who have had 
prolonged, frequent, or intense contact with the TB 
case while the case was infectious.  
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Step	4:	Risk	Assessment	for	
M.	Tuberculosis	Transmission
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Step	5:	Decision	about	Priority	of	
Contacts
Efficient use of resources in a contact investigation 
focuses on high priority contacts.
 High priority contacts are:
§ Contacts who are most likely to be infected, based 
on the risk that M. tuberculosis was transmitted.
§ Contacts who are at high risk of developing 
disease if infected, including young children less than 
4 years of age, HIV-infected and other 
immunosuppressed persons, and persons with certain 
medical conditions. 
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Step	5:	Decision	about	Priority	of	
Contacts
The table shown includes factors to 
determine a contact’s risk of becoming 
infected.  
Examples of close contacts include: 
 Family members who live in the same 
home.
 A coworker who works alongside the 
patient each day for several hours in a 
small area.
 A person that drinks with the patient at 
a local bar for a few hours, 3 times a 
week.
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Step	6:	Evaluation	of	Contacts
Evaluation of TB contacts should be done in an 
orderly manner, starting with the highest-priority 
group of contacts.
 Contacts should be evaluated for LTBI and TB disease. This 
evaluation should include at least: 
§ A medical history AND
§ A Mantoux tuberculin skin test (unless there is a previous 
documented positive reaction)  or IGRA test. 
 For immunosuppressed contacts or contacts who are under 4 
years of age, the evaluation should also include a chest x-ray, 
regardless of skin test result, because of the possibility of a 
false-negative reaction to the tuberculin skin test and risk of 
early progression to TB disease if infected.
 Any contact who has TB symptoms should be given both a 
chest x-ray and a sputum examination. 
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Step	6:	Evaluation	of	Contacts
Medical history
 History of TB infection or disease. 
 Documented previous tuberculin skin 
test results. 
 Previous treatment for TB infection or disease. 
 Previous exposure to TB. 
 Risk factors for developing TB disease. 
 Current symptoms of TB. 
 Risk factors for HIV and offer of counseling and 
testing if their HIV status is not known and they are 
at risk. 
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Step	6:	Evaluation	of	Contacts
Mantoux tuberculin skin test in a contact investigation.
 High priority contacts with a ≥ 5mm of induration are considered 
positive.
 People with a positive reaction, regardless of whether or not 
vaccinated with BCG, should be further evaluated for TB disease.
 Contacts with previously documented positive TST should not 
receive another test but should be evaluated for symptoms of TB 
disease, asked about history of treatment for TB infection/disease, 
and may need a chest x-ray.
 TST administered to contacts less than 10-12 weeks (window 
period) after their exposure may have a false negative reaction.  It 
takes 2-12 weeks after TB infection for the body’s immune system 
to react to tuberculin.  
§ Re-test 10-12 weeks after the last contact with the infectious case. 
 After window period, all contacts with initially negative reaction skin 
should be given a repeat test. 
USF - TB Fundamentals & Response Planning 2016 183
Step	6:	Evaluation	of	Contacts
Chest X-ray
 All contacts with positive TST with 
induration of ≥ 5mm or who report TB 
symptoms
 Rule out possibility of TB disease and look 
for signs of old TB disease before LTBI 
treatment is started. 
Chest x-ray should be conducted at the same time as the 
initial skin test for contacts that:
 Have TB symptoms. 
 Are HIV-infected or have other immunosuppressed 
conditions. 
 Are under 4 years of age. 
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Step	6:	Evaluation	of	Contacts
Sputum examination
 Any contact with abnormal chest 
x-ray or with TB symptoms. 
 3 sputum specimens collected on 
3 different days for smear and culture 
examination regardless of TST results. 
 Smear results are used to determine person’s 
infectiousness.
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Step	7:	Treatment	and	Follow-Up	for	
Contacts	
Evaluated for treatment of LTBI
 Contacts who have a positive tuberculin 
skin test reaction and no evidence of TB 
disease. 
 High-risk contacts who have a negative tuberculin skin test 
reaction:
§ Children under 4 years of age. 
(Prophylaxis is usually administered during the window period, 
and after the second negative TST, treatment is stopped.)
§ HIV-infected or other immunosuppressed people. 
§ Other high-risk contacts who may develop TB disease very 
quickly after infection. 
 Contacts recently infected with M. tb.
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Step	8:	Decision	About	Whether	to	
Expand	Testing
Contacts should be tested in the order of their exposure time and risk, 
starting with the highest-priority group (concentric circle approach).
 Decisions about expanding contact investigations to the next group 
of contacts should be made by clinical and supervisory staff based 
on an assessment of all available information.
 If there is NO evidence of recent TB transmission, then testing 
should NOT be expanded to the next group of contacts. 
 If there IS evidence of recent transmission, the next highest priority 
group should be evaluated. 
Note: The investigation should expand to the next group each time 
there is evidence of transmission in the group being tested. The 
particular circumstances of each case need to be carefully considered 
in order to expand testing to include all those likely to be at risk.
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Step	8:	Decisions	About	Whether	
to	Expand	Testing
Concentric Circle Method
Evidence of recent TB transmission among 
the high-priority contacts determines 
whether the next group of contacts should 
be screened.
§ High infection rate (percentage of 
contacts with a similar amount of 
exposure who have a newly identified 
positive skin test reaction). 
§ TB infection in a young child.
§ Documented contact skin test conversion.
§ Secondary case of TB.
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Step	9:	Evaluation	of	Contact	
Investigation	Activities
 Program evaluation is an important part 
of any program.
 Effective and successful contact investigations can help 
prevent additional cases of TB infection and disease and 
reduce further transmission of M. tuberculosis.
The results of the evaluation are used to: 
• Determine effectiveness. 
• Identify areas in need of improvement. 
• Prioritize program activities and resources.
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Step	9:	Evaluation	of	Contact	Investigation	
Activities
To complete the investigation, a supervisor 
evaluates:  
 Were an appropriate number of contacts identified? 
 Were the highest-priority contacts located and tested? 
 Was the contact investigation performed in all settings -
household or residence, work or school, and leisure or 
recreational environments? 
 Was the contact investigation expanded appropriately? 
 Were contacts completely evaluated (including second skin test if 
needed) and given appropriate therapy if they had TB infection or 
disease? 
 How many infected contacts completed a regimen of treatment for 
LTBI? 
 Did all identified cases complete an adequate treatment regimen? 
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Exercise	4:	Contact	Investigation	
For this activity, group persons from         
similar/same organizations together.
 Using the protocol template, consider what you 
have learned in the fourth section. How would 
your organization manage a TB contact 
investigation? 
 Record your responses on the flip chart.
§ Use the smaller template for your notes.
 The next slide shows you an example of how to 
complete the template.
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Creation	of	Protocol	– Contact	Investigation
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Exercise	4:	Contact	Investigation
Now that your team has recorded your template 
responses on the flip chart, rotate as a team 
clockwise and review how other teams have 
responded.
 Do you understand each step in their protocol?
§ If NOT, use a colored sticky note to let the team know what needs to 
be further clarified.
 Is there an additional Action, Lead, Experience, Resources, 
Timeframe, Achievement Review, or Review Date the team 
should add?
§ Add additional information in a different color marker to the flip chart.  
 Conduct this review for each team until you are back to your 
starting team. 
§ Review the critiques of the other teams, and incorporate any of the 
recommendations that your team deem appropriate. 
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Core Steps of a Tuberculosis 
Outbreak Investigation
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Core	Steps	of	a	TB	Outbreak	
Investigation
1. Confirm that it meets epidemiologic 
definition of an outbreak (any one 
of the following): 
a. More cases than expected (surveillance).
b. Cases epidemiologically clustered by time, space, or 
common behaviors.
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Core	Steps	of	a	TB	Outbreak	
Investigation
2. Consider whether there is ongoing transmission (one of the 
following): 
a. Did regular contact investigations reveal epidemiologic 
links or similarities among cases?
b. Did the laboratory identity a genotyping cluster that 
confirms the epidemiologic links identified by regular 
contact investigation?
c. Did the laboratory identify a genotyping or 
epidemiologic cluster of lab isolates clustered in time 
and space where there is discordance between the 
clinical course of the patient and the laboratory results 
(false-positive culture)?
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Core	Steps	of	a	TB	Outbreak	
Investigation
3. Define an outbreak-related case.
4. Confirm existing number of outbreak-related cases.
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Core	Steps	of	a	TB	Outbreak	
Investigation
5. Investigate existing outbreak-related cases by reviewing: 
a. History, physical, clinical chart, and notes.
b. Laboratory records (serial results of smears, cultures, drug 
sensitivities, and other testing) and medical records. 
c. Genotyping results for all culture-positive cases (if not already 
done, submit isolates for genotyping). 
d. Chest radiographs (including old baseline films, if possible).
e. Tuberculosis clinic and other pertinent public health records.
f. Cross-match of outbreak-related cases with county jail, state 
prison, and STD registries.
g. All data from regularly conducted contact investigations 
(re-interview case-patients and their contacts as necessary).
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Core	Steps	of	a	TB	Outbreak	
Investigation
6. Determine the infectious period for each outbreak-related 
case based on: 
a. Laboratory results (e.g., sputum smear-positive 
patients are thought to be more infectious).
b. Serial chest radiographs (e.g., patients with cavitary
lung lesions are thought to be more infectious).
c. Date of onset and duration of signs and symptoms. 
d. Results of screening of named contacts (e.g., a high 
percentage of TST-positive contacts).
USF - TB Fundamentals & Response Planning 2016 199
Core	Steps	of	a	TB	Outbreak	
Investigation
7. Determine the sites and facilities frequented and family and 
social groups exposed by outbreak-related patients during 
their infectious periods, using:
a. Information from case-patient interviews and contact 
investigations.
b. Information from medical and public health records.
c. Information from the facility logs or records.
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Core	Steps	of	a	TB	Outbreak	
Investigation
8. Determine the exposed cohort of persons at each 
site/facility who may have been present when an 
outbreak-related case-patient was present during 
his/her infectious period, using: 
a. Information from case-patient interviews and contact 
investigations.
b. Information from medical and public health records.
c. Information from the facility logs or records.
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Core	Steps	of	a	TB	Outbreak	
Investigation
9. Determine the duration by number of hours, days, or 
weeks. for the exposed cohort of persons who may 
have spent around an infectious outbreak-related 
patient, using: 
a. Information from case-patient interviews and contact 
investigations.
b. Information from medical and public health records.
c. Information from the facility logs or records.
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Core	Steps	of	a	TB	Outbreak	
Investigation
10. Prioritize exposed cohorts for screening (active case 
finding and latent TB infection) based on: 
a. Type (e.g., indoor versus outdoor, intimate versus 
casual), frequency, and duration of exposure.
b. Risk of progression to active disease.
11. Define elements of and action plan for screening, 
implementation, and follow-up.
12. Identify resources necessary for action plan to be 
carried out.
13. Create a media plan to respond to possible inquiries.
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Core	Steps	of	a	TB	Outbreak	
Investigation
14. Assign responsibilities and set deadlines.
15. If necessary, expand screening to include low-priority 
cohorts after screening high-priority cohorts based on 
evidence of transmission.
16. Evaluate, treat, and follow up additional TB disease 
case patients and latent TB infected persons 
associated with this outbreak.
17. Make and implement recommendations to prevent 
future outbreaks for particular populations or settings 
involved.
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Investigation
18. Evaluate outbreak response. 
19. Determine whether interventions have effectively 
stopped TB transmission in this situation.
20. Identify the lessons learned that could improve the 
public health response to the next outbreak.
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Exercise	5:	TB	Outbreak	
For this activity, group persons from 
similar/same organizations together.
 Using the protocol template, consider what you have 
learned in the fifth section. 
 How would your organization manage a TB outbreak? 
 How would your organization manage a TB outbreak 
among multiple organizations?
 Record your responses on the flip chart.
§ Use the smaller template for your notes.
 The next slide shows you an example of how to 
complete the template.
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Creating	a	Protocol	– Managing	a	TB	
Outbreak
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Exercise	5:	TB	Outbreak
Now that your team has recorded your template 
responses on the flip chart, rotate as a team clockwise 
and review how other teams have responded.
 Do you understand each step in their protocol?
§ If NOT, use a sticky note to let the team know what needs to be further 
clarified.
 Is there an additional Action, Lead, Experience, Resources, 
Timeframe, Achievement Review, or Review Date the team 
should add?
§ Add additional information in a different color marker to the flip chart.  
 Conduct this review for each team until you are back to your 
starting team. 
§ Review the critiques of the other teams, and incorporate any of the 
recommendations that your team deem appropriate. 
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Course Completion
and Next Steps
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Course	Completion	Activities	
1. Onsite Post Assessment
2. Course Evaluation – Please complete 
and submit the course evaluation. 
3. Course Completion Certificate – You will 
receive a certificate of completion at the 
end of this training.
4. Continuing Education Credits Form – Everyone 
needs to complete SRAHECand turn it in before 
leaving the training.
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Thank	you	for	
your	
participation!
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